Mylan N V Revenue per Employee (MYL), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Mylan N v   (NASDAQ: MYL)
 

Mylan N V 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 0.35% in the third quarter 2020, year on year to cumulative value of $11,514 million, Mylan N V 's revenue per employee grew on a trailing twelve months basis to $ 328,980. The productivity of Mylan N V 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 7 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 405, from total ranking in previous quarter at 526. Mylan N V has 35,000 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MYL Revenue per Employee (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Revenue Change 0.35 % -4.22 % 4.96 % 3.67 % 3.47 %
Sales per Employee (TTM) $ 328,980 328,683 332,120 328,586 325,354
MYL's Total Ranking # 405 # 526 # 0 # 0 # 0
Seq. Revenue Change 8.82 % 4.28 % -17.94 % 7.77 % 3.86 %

MYL Company Profile >> Back to MYL Efficiency Comparisons >> Compare MYL Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 4
Healthcare Sector # 8
Overall Market # 405

Revenue per Employee Statistics
High Average Low
$ 674,452 $ 274,925 $ 49,151
(Sep 30 2020)   (Sep. 30, 2005)



Financial Statements
Mylan N V 's Revenue MRQ $ 2,972 Millions Visit MYL's Income Statement
Mylan N V 's Revenues TTM $ 11,514 Millions Visit MYL's aggregate revenue growth
What are MYL's Sales? Visit MYL's Sales by Segment




Other Ratios
Mylan N V 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MYL's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MYL's Competitors
Revenue per Employee for MYL's Suppliers
Revenue per Employee for MYL's Customers

You may also want to know
MYL's Sales Growth Rates MYL's Pe Price to earnings ratio MYL's Receivables Turnover Ratio MYL's Stock Quote
MYL's Net Income Growth Rates MYL's Ps Price to Sales ratio MYL's Sales per Employee MYL's Asset Turnover Ratio
MYL's Net Margin MYL's Pb Price to Book ratio MYL's Financial Strength Ratios MYL's Dividend Payout Ratio
Date modified: 2026-09-08T15:10:04+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2020, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2020Number of Employees Sep 30 2020
Johnson and Johnson  574,261.36 $ 80,856.000  Million 140,800 
Alkermes Plc   571,459.02 $ 1,171.491  Million 2,050 
Healthlynked Corp  571,148.20 $ 5.711  Million 10 
Paratek Pharmaceuticals Inc   561,577.46 $ 39.872  Million 71 
Wearable Health Solutions, Inc.  560,300.00 $ 1.121  Million 2 
Dynatronics Corporation  558,548.47 $ 49.152  Million 88 
Omeros Corporation  551,988.57 $ 96.598  Million 175 
Fortress Biotech Inc   551,025.64 $ 42.980  Million 78 
Korro Bio Inc   547,293.10 $ 31.743  Million 58 
Regeneron Pharmaceuticals Inc   534,957.82 $ 8,243.700  Million 15,410 
Hologic Inc  534,158.42 $ 3,776.500  Million 7,070 
Kaya Holdings Inc   533,351.00 $ 1.067  Million 2 
Acadia Pharmaceuticals Inc   525,155.39 $ 419.074  Million 798 
3m Company  524,165.29 $ 31,712.000  Million 60,500 
Cerus Corporation  521,284.72 $ 150.130  Million 288 
Neurocrine Biosciences Inc   521,005.00 $ 1,042.010  Million 2,000 
Opko Health Inc   512,123.52 $ 1,165.081  Million 2,275 
Pacira Biosciences inc   507,957.78 $ 421.097  Million 829 
Thermogenesis Holdings Inc   501,000.00 $ 9.519  Million 19 
Masimo Corp  498,272.73 $ 1,096.200  Million 2,200 
Yunhong Green Cti Ltd   497,114.35 $ 25.850  Million 52 
Enovis Corp  497,021.02 $ 3,877.758  Million 7,802 
Venus Concept Inc   496,572.37 $ 150.958  Million 304 
Corcept Therapeutics Inc  487,717.81 $ 356.034  Million 730 
Amicus Therapeutics inc   480,641.88 $ 245.608  Million 511 
Smiledirectclub Inc   477,812.86 $ 668.938  Million 1,400 
Vapotherm Inc   477,248.78 $ 97.836  Million 205 
Teva Pharmaceutical Industries Limited  477,054.49 $ 16,196.000  Million 33,950 
Luna Innovations Inc  476,343.27 $ 76.215  Million 160 
Halozyme Therapeutics Inc   471,763.59 $ 199.556  Million 423 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.